Back to search

Article

A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery

2019-09-29

Abstract excerpt

Immune checkpoint blockade of programmed death-1 (PD-1) by monoclonal antibody drugs has delivered breakthroughs in the treatment of cancer. Nonetheless, small-molecule PD-1 inhibitors could lead to increases in treatment efficacy, safety, and global access. While the ligand-binding surface of apo-PD-1 is relatively flat, it harbors a striking pocket in the murine PD-1/PD-L2 structure. An analogous pocket in human...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4406636-8e15-5b20-b74c-163f3bb77a76
DOI
10.1101/786319
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discoveryDOI 10.1101/786319
Select a neighboring publication to make it the new centre.